Skin of Color
Amid growing concerns, professional societies, FDA, and physician leaders are urging clinicians to rely exclusively on pharmaceutical-quality, approved products from licensed vendors.
Paul Winnington, Editorial Director
Joel Schlessinger, MD, FAAD Chief Cosmetic Surgery Editor
The SEO approach to marketing is rapidly undergoing a paradigm shift. Are you geared up for the change?
Naren Arulrajah with Vikas Vij
After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.
Professor Begona Calvo
Developers are eyeing new therapeutic targets for biologic treatments for psoriasis.
Mark A. Bechtel, MD; Amy L. Levinson, BA, BSN, RN; Anne M. Bechtel, BSN, RN
Ronald Prussick, MD, and Lisa Prussick, BSC
The road from prescription to administering biologic agents may not always be smooth, but these clinical and practical tips will help to expedite the process.
Jerry Bagel, MD
Intralesional cryosurgery appears to allow for focused destruction of keloid scar tissue with minimal damage to the surface of the skin.
Adam Luber, BA, and Gary Goldenberg, MD
A recently published study dampens expectations for the future of EHRs, which may also signal diminished public support.
Mark Kaufmann, MD
Limited data suggest the possibility that some natural agents may be particularly useful in the treatment of atopic dermatitis.
Peter A. Lio, MD
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.
February 2013 Insert